NCT00711347View on ClinicalTrials.gov

Intraoperative Floppy Iris Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
CataractFloppy Iris Syndrome
Interventions
DEVICE

DisCoVisc

Use of Alcon's DisCoVisc Ophthalmic Viscosurgical Device(4% sodium chondroitin sulfate, 1.65% sodium hyaluronate) during cataract surgery with intraocular lens implantation.

DEVICE

Healon5

Use of Abbott Medical Optics (AMO) Healon5 Ophthalmic Viscosurgical Device (2.3% Sodium Hyaluronate) during cataract surgery with intraocular lens implantation.

Trial Locations (1)

76134

Contact Alcon Call Center for Study Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY